GSK Pharma Q2 profit down 23 Percent to Rs 101 crore
New Delhi: GlaxoSmithKline(GSK)Pharmaceuticals has reported 22.67 per cent fall in standalone net profit to Rs 100.77 crore for the quarter ended September 30, 2018. The company had posted a net profit of Rs 130.32 crore in the year-ago period, GSK Pharma said in a BSE filing.
Total income of the company stood at Rs 831.13 crore for the reported quarter. It was Rs 845.89 crore in the second quarter of 2017-18.
Read Also: GSK resumes some doctor payments, backtracking on blanket ban
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd